Ozempic Approved By FDA For Kidney Disease—In Ultra-Popular Drug’s Latest Approval
Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...
Hosted on MSN10h
FDA grants 510(k) clearance for Imperative Care’s stroke thrombectomy system
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Imperative Care’s Zoom System, marking an ...
FDA authorizes Zyn nicotine pouches, cites lower risk than cigarettes
The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine ...
Rolling Out4d
FDA unveils 8 critical safety measures for berry industry
FDA introduces comprehensive safety measures targeting norovirus and hepatitis A in fresh and frozen berries, addressing ...
pharmaphorum23d
Marking Rare Disease Day, FDA and patient group launch collaboration
The FDA has marked today’s international Rare Disease Day with a number of measures to promote research and patient participation in policy and research. Among the new measures announced ...
health.wusf.usf.edu11d
Zyn nicotine pouches can be marketed in the U.S., the FDA says. What does this mean?
Federal health officials have authorized the marketing and sale of Zyn nicotine pouches, marking the first time the Food and ...
PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
ophthalmologytimes3d
Pantheon Vision completes third pre-submission meeting with the FDA
The meetings support the company’s submission for its bioengineered corneal implants to eliminate corneal blindness.
Pharm Exec7d
FDA Approves Johnson & Johnson’s Spravato for Treatment-Resistant Depression
CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD).